Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Stroke Prevention in Atrial Fibrillation Study. Final results.

[No authors listed]

Circulation. 1991 Aug;84(2):527-39.

PMID:
1860198
2.

Prevention of stroke in patients with nonvalvular atrial fibrillation.

Hart RG, Sherman DG, Easton JD, Cairns JA.

Neurology. 1998 Sep;51(3):674-81. Review.

PMID:
9748009
3.

Preventing stroke in patients with nonrheumatic atrial fibrillation.

Nelson KM, Talbert RL.

Am J Hosp Pharm. 1994 May 1;51(9):1175-83. Review.

PMID:
8042636
4.

Anticoagulant therapy for atrial fibrillation. Recommendations from major studies.

Kahn JK.

Postgrad Med. 1992 Sep 1;92(3):119-24, 129-30. Review.

PMID:
1518749
5.

Prevention of thromboembolic events in atrial fibrillation.

Koefoed BG, Gulløv AL, Petersen P.

Thromb Haemost. 1997 Jul;78(1):377-81. Review.

PMID:
9198182
6.

Antithrombotic therapy in atrial fibrillation.

Turpie AG, Connolly SJ.

Can Fam Physician. 1996 Jul;42:1341-5. Review.

7.

Atrial fibrillation and stroke. Three new studies, three remaining questions.

Albers GW.

Arch Intern Med. 1994 Jul 11;154(13):1443-8. Review.

PMID:
8017999
8.
9.

Warfarin for the prevention of systemic embolism in patients with non-valvular atrial fibrillation: a meta-analysis.

Andersen LV, Vestergaard P, Deichgraeber P, Lindholt JS, Mortensen LS, Frost L.

Heart. 2008 Dec;94(12):1607-13. doi: 10.1136/hrt.2007.135657. Epub 2008 Jan 20. Review.

PMID:
18208828
10.

Lessons from the Stroke Prevention in Atrial Fibrillation trials.

Hart RG, Halperin JL, Pearce LA, Anderson DC, Kronmal RA, McBride R, Nasco E, Sherman DG, Talbert RL, Marler JR; Stroke Prevention in Atrial Fibrillation Investigators.

Ann Intern Med. 2003 May 20;138(10):831-8. Review.

PMID:
12755555
11.

Apixaban for stroke prevention in atrial fibrillation: a review of the clinical trial evidence.

Yates SW.

Hosp Pract (1995). 2011 Oct;39(4):7-16. doi: 10.3810/hp.2011.10.918. Review.

PMID:
22056819
12.

Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.

Cairns JA, Connolly S, McMurtry S, Stephenson M, Talajic M; CCS Atrial Fibrillation Guidelines Committee.

Can J Cardiol. 2011 Jan-Feb;27(1):74-90. doi: 10.1016/j.cjca.2010.11.007.

PMID:
21329865
15.

Apixaban and atrial fibrillation: no clear advantage.

[No authors listed]

Prescrire Int. 2014 Feb;23(146):33-6. Review.

PMID:
24669381
16.

Antithrombotic therapies for stroke prevention.

Solomon DH, Hart RG.

Curr Opin Neurol. 1994 Feb;7(1):48-53. Review.

PMID:
8173677
17.

Primary and secondary stroke prevention in atrial fibrillation.

Anderson DC.

Semin Neurol. 1998;18(4):451-9. Review.

PMID:
9932616
18.

Non-rheumatic atrial fibrillation: warfarin or aspirin for all?

Nolan J, Bloomfield P.

Br Heart J. 1992 Dec;68(6):544-7; discussion 547-8. Review. No abstract available.

19.

Antithrombotic treatment for the primary prevention of stroke in patients with non valvular atrial fibrillation: a reappraisal of the evidence and network meta analysis.

Owen A.

Int J Cardiol. 2010 Jul 23;142(3):218-23. doi: 10.1016/j.ijcard.2009.11.045. Epub 2010 Jan 12. Review.

PMID:
20061035
20.

Risk of stroke or systemic embolism in atrial fibrillation patients treated with warfarin: a systematic review and meta-analysis.

Albertsen IE, Rasmussen LH, Overvad TF, Graungaard T, Larsen TB, Lip GY.

Stroke. 2013 May;44(5):1329-36. doi: 10.1161/STROKEAHA.113.000883. Epub 2013 Mar 12. Review.

Supplemental Content

Support Center